# OnCo record paper-e1910-blinatumomab-mrd-negative-all-nejm-2024 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-e1910-blinatumomab-mrd-negative-all-nejm-2024/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-e1910-blinatumomab-mrd-negative-all-nejm-2024" ;
  schema:name "ECOG-ACRIN E1910: adding blinatumomab to chemotherapy for adults with B-cell ALL already in MRD-negative remission"@en ;
  schema:description "Giving the bispecific blinatumomab to adults whose leukaemia was already undetectable after chemotherapy raised three-year survival from 68% to 85%."@en ;
  schema:url <https://onco.cc/key-papers/paper-e1910-blinatumomab-mrd-negative-all-nejm-2024/> ;
  schema:dateModified "2026-09-08"^^xsd:date ;
  schema:citation <https://doi.org/10.1056/NEJMoa2312948>, <https://clinicaltrials.gov/study/NCT02003222> ;
  schema:sameAs <https://doi.org/10.1056/NEJMoa2312948> ;
  schema:datePublished "2024"^^xsd:gYear ;
  schema:author "Litzow MR, Sun Z, Mattison RJ, et al." ;
  onco:related <https://onco.cc/pairings/blinatumomab-frontline-consolidation/>, <https://onco.cc/key-papers/paper-aall1731-blinatumomab-children-nejm-2025/> ;
  onco:cancers <https://onco.cc/cancers/all-leukemia/> ;
  onco:technologies <https://onco.cc/technologies/bispecific-antibody/>, <https://onco.cc/technologies/t-cell-engager/>, <https://onco.cc/technologies/mrd-testing/> ;
  onco:targets <https://onco.cc/targets/cd19/>, <https://onco.cc/targets/cd3/> ;
  onco:drugs <https://onco.cc/drugs/blinatumomab/> ;
  onco:companies <https://onco.cc/companies/amgen/>, <https://onco.cc/companies/ecog-acrin/> ;
  onco:terms <https://onco.cc/terms/mrd/>, <https://onco.cc/terms/os/>, <https://onco.cc/terms/mrd-negative-cr/> ;
  onco:trials <https://onco.cc/trials/e1910/> ;
  onco:people <https://onco.cc/people/mark-litzow/> ;
  onco:bottlenecks <https://onco.cc/bottlenecks/b-dormancy-mrd/> ;
  onco:journals <https://onco.cc/journals/nejm/> .